Turning cold tumors hot: from molecular mechanisms to clinical applications

Zhang, Jiahui, Huang, Di, Saw, Phei Er, Song, Erwei·2022·Trends in Immunology

Cited by (544)

Items 301–400 of 544

  1. Construction of Two Independent RAB Family-Based Scoring Systems Based on Machine Learning Algorithms and Definition of RAB13 as a Novel Therapeutic Target for Hepatocellular Carcinoma
    Chenhao Jiang, Zijian Liu, Jingsheng Yuan, Zhenru Wu, Lingxiang Kong, Jiayin Yang, Tao Lv · 2023 · International Journal of Molecular Sciences
  2. Mini-review: the distinct roles of STING signaling in tumor immunity—recent progress
    Shengli Wang, Tao Li, Hongyan Sun, Danchun Chen, Hongbiao Xu, Jianlei Hao · 2023 · Journal of Leukocyte Biology
  3. Prognostic and immunotherapeutic implications of bilirubin metabolism‐associated genes in lung adenocarcinoma
    Kangqi Ren, Xiean Ling, Chen Lin, Zeyao Li, Tonghai Huang · 2024 · Journal of Cellular and Molecular Medicine
  4. Prognostic Value and Immune Signatures of Anoikis-related Genes in Breast Cancer
    Qing Wu, Luo Yang, Nan Lin, Shiyao Zheng, Xianhe Xie · 2024 · Journal of Immunotherapy
  5. Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity
    Sayumi Yamazoe, Yam B. Poudel, Emanuela I. Sega, Anandaroop Mukhopadhyay, Radha Ramakrishnan, Okechukwu T. Ukairo, Scot D. Liu, Rahima Akter, Keerthi Caroline Sadanala, Kathryn Que et al. · 2025 · Journal of Medicinal Chemistry
  6. A customized immunomodulator reinforces the T cell-mediated immunological cascade for cancer therapy
    Guowang Cheng, Jiaxin Wu, Wei Liu, Yumiao Yang, Hao Cui, Xiuxiu Dai, Bowen Li, Zhen Tian, Xiaojia Chen, Xiaohui Li et al. · 2025 · Chemical Engineering Journal
  7. RNA vaccines for cancer: revolutionizing immunization strategies
    Di Huang, Jiahui Zhang, Xin Zeng, Yin Zhang, Erwei Song · 2025 · Trends in cancer
  8. Integrated pathway analysis identifies prognostically relevant subtypes of glioblastoma characterized by abnormalities in multi‐omics
    Pei Zhang, Dan Liu, Tonghui Yu, Yanlin Zhang, Lu Xing Zhong, Xiao Ouyang, Xia Qin, Lei Dong · 2025 · Clinical and Translational Medicine
  9. cGAS/STING-mediated γδ T cell recruitment drives radioresistance: implications for improving radioimmunotherapy outcomes
    Brooke C Braman, David Ronan Raleigh · 2025 · Journal of Clinical Investigation
  10. Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytes
    Simon A. Grassmann, Endi K. Santosa, Hyunu Kim, Isabelle B. Johnson, Adriana M. Mujal, Jean-Benoît Le Luduec, Sherry Fan, Mark Owyong, Adrian Straub, Liang Deng et al. · 2026 · Immunity
  11. AI-driven radiogenomics in gynecologic oncology: from radiological digital biopsy to a new paradigm in precision therapy
    KONG Qiqi, Yunqing Ban · 2026 · Frontiers in Oncology
  12. Targeting cytokine/chemokine signaling to convert immunologically cold tumors into hot: Emerging strategies in cancer immunotherapy
    Jung Hee Park, Dae Ui Lee, Jongbin Jeong, Kyung Hee Jung, Soon‐Sun Hong · 2026 · Acta Pharmaceutica Sinica B
  13. Microvascular and stromal normalization combined with nano-immunotherapy: A synergistic strategy to overcome drug delivery barriers in solid tumors
    Fatemeh Mirala, Farshad Moradi Kashkooli, M. Soltani · 2026 · Microvascular Research
  14. Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological Malignancies
    Sevgi Gezici · 2023 · Elsevier eBooks
  15. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis
    Yongfeng Wang, Yanzong Zhao, Guangming Zhang, Yifeng Lin, Chunling Fan, Hui Wei, Shude Chen, Ling Guan, Kan Liu, Sixian Yu et al. · 2024 · Scientific Reports
  16. Effect of cryoablation on the spatial transcriptomic landscape of the immune microenvironment in non-small cell lung cancer
    Jun Zhou, Shengxi Wang, Ming Liu, Zhaopei Li · 2024 · Journal of Cancer Research and Therapeutics
  17. Functional Materials Targeted Regulation of Gasdermins: From Fundamentals to Functionalities and Applications
    Luyao Tian, Shuo Piao, Xia Li, Lanping Guo, Luqi Huang, Wenyuan Gao · 2025 · Advanced Science
  18. Targeting DKK3 to remodel tumor immune microenvironment and enhance cancer immunotherapy
    Kai Shi, Yan Zhao, Hao Ye, Xiaoming Zhu, Zhenghai Chen · 2025 · BMC Cancer
  19. Nuclear glycine decarboxylase suppresses STAT1-dependent MHC-I and promotes cancer immune evasion
    Rui Liu, Hui-Fang Li, Qi Jiang, Jun-Ge Shi, Zi-Lun Ruan, Peng Ren, Yinuo Li, Hong‐Bing Shu, Shu Li · 2025 · The EMBO Journal
  20. A pan-cancer analysis revealed SKP2 as an inhibitor of the tumor immune microenvironment and a promising therapeutic target for immunotherapy
    Xingyu Liao, Yaxin Zhang, Xue Qing Yu, Wei Du, Linxi Chen, Zhiqing Zhao, Haijie Liang, Xingyu Liu, Feiyang Qi, David S Geller et al. · 2025 · Precision Clinical Medicine
  21. In vivo visualization of immunosuppressive cells in the tumor microenvironment
    Guangfa Bao, Jianyuan Zhou, Siyuan Cheng, Jun Zhao, Xiaohua Zhu · 2023 · iRadiology
  22. Prognostic and therapeutic insights into colorectal carcinoma through immunogenic cell death gene profiling
    Jing-Lu Yu, Yabin Gong, Zhenye Xu, Lei Chen, Shuang Li, Yongkang Cui · 2024 · PeerJ
  23. Pan-cancer analysis of Sp1 with a focus on immunomodulatory roles in gastric cancer
    Yang Zhou, Zhenzhen Luo, Jinfeng Guo, Lixia Wu, Xiaoli Zhou, Jun Jie Huang, Daijia Huang, Xiao Li, Qiuhua Duan, Jianhua Chang et al. · 2024 · Cancer Cell International
  24. Bortezomib induces cell apoptosis and increases the efficacy of αPD-1 in BCR::ABL T315I mutation CML by targeting UBE2Q1
    Fengyu Jiang, Wenjie Liu, Yanyu Zhou, Siwei Lin, Qin Zhang, Wan Zhang, Yangyang Xue, Chao Li, Anran Gao, Miaomiao Shao et al. · 2024 · International Immunopharmacology
  25. Control of aggressive 4T1-luc metastatic breast cancer using immunogenic cell lysates generated with methotrexate
    Luana Cristina Camargo, Pedro Burgel, Camila Magalhães Cardador, Victor Carlos Mello da Silva, Karen L. R. Paiva, Marina Mesquita Simões, Raffael Júnio Araújo de Castro, Isabel Martinello Valente, Gabriel Ribeiro Farias, Thais Bergmann de Castro et al. · 2025 · Biomedicine & Pharmacotherapy
  26. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer
    Qing Wu, Shiyao Zheng, Nan Lin, Xianhe Xie · 2023 · BMC Medical Genomics
  27. A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing
    Xu Chen, Chuang Peng, Yu Chen, Bai Ding, Sulai Liu, Yinghui Song, Yuhang Li, Bo Sun, Ranzhiqiang Yang · 2023 · BMC Bioinformatics
  28. Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma
    Valentina B. Stevenson, Erwin Kristobal Gudenschwager Basso, Shawna L. Klahn, Tanya LeRoith, William R. Huckle · 2023 · Veterinary and Comparative Oncology
  29. Integrative analysis of single-cell and bulk RNA-sequencing data revealed T cell marker genes based molecular sub-types and a prognostic signature in lung adenocarcinoma
    Yue-Ling Peng, Yafang Dong, Qihui Sun, Yue Zhang, Xiangyang Zhou, Xiaoyang Li, Yuehong Ma, Xingwei Liu, Rongshan Li, Fengjie Guo et al. · 2024 · Scientific Reports
  30. Emerging Therapeutic Approaches Targeting Ferroptosis in Cancer: Focus on Immunotherapy and Nanotechnology
    Zongchao Yu, Zhongcheng Mo, Yuan Qiu, Hengzhe Lu, Biao Zheng, Longfei Liu · 2024 · Current Pharmaceutical Biotechnology
  31. Pan‐cancer analysis of DCTN2 and its tumour‐promoting role in HCC by modulating the AKT pathway
    Shuning Xu, Jiyuan Xing, Ke Li, Lei Qiao, Cheng Zhang, Yulin Ren, Ying Liu · 2024 · Journal of Cellular and Molecular Medicine
  32. Necroptosis-related lncRNAs: establishment of a gene module and distinction between the cold and hot tumors in glioma
    Kangxi Cao, Fengbo Su, Xuchun Shan, Xingyu Jiang, Zhaohui Ni, Yan Chen · 2023 · Frontiers in Oncology
  33. Lymphocyte subsets and inflammatory factors as predictors of immunotherapy efficacy in patients with hepatocellular carcinoma
    Gao Shuyue, Jiamin Cheng, Niansong Qian · 2023 · Scientific Reports
  34. Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
    Daciana Catalina Dumut, Marián Hajdúch, Amanda M Zacharias, Qingling Duan, Ivo Frydrych, Zuzana Rozankova, Miroslav Popper, Dušan Garić, Radu Alexandru Paun, Amanda Centorame et al. · 2025 · Frontiers in Immunology
  35. Vascular-Targeted Nanoplatform for Enhanced Immunotherapy via Synergistic Thrombosis and Hypoxia-Activated Chemotherapy
    Pengfei Yuan, Tianci Zhu, Xiaodie Yan, Wen Liu, Lamei Liu, Xiaoqing Zong, Caiqi Yang, Xinjie Chen, Siying Wei, Yaoqi Wen et al. · 2025 · ACS Applied Materials & Interfaces
  36. Comprehensive Pan-Cancer Analysis Identifies IGFL1 as an Oncogenic Biomarker and Immunotherapeutic Target with Experimental Validation in Bladder Cancer
    Zongjian Liang, Yu An, Jie He, Zhiqiang Zhu, Kehua Jiang, Kun Chen, Fa Sun · 2025 · International Journal of General Medicine
  37. Phenotypic Plasticity, Non-genetic Mechanisms, and Immune Drug Resistance in Cancer
    Prakash Kulkarni, Sravani Keerthi Ramisetty, Débora S. Bruno, Tingting Tan, Amartej Merla, Ravi Salgia · 2025 · Cancer treatment and research
  38. Chinese medicines as therapeutic options for treating prostate cancer: Therapeutic effects and underlying mechanisms
    Shenglong Li, Shuaishuai Jing, Jiuyun Zhou, Hui Li, Pengdong Yin, Qingwei zhang, Mei-Sheng Gong, Yongqiang Zhao, Gang-Gang Lu, Gi-Heang Jin et al. · 2025 · Journal of Ethnopharmacology
  39. Engineering a garlic-derived nanovesicle/microneedle system to boost melanoma immunotherapy through self-amplifying cell death activation and immune remodelling
    Jing Li, Jie Wang, Bingqian Li, Meng Long, Xiumei Liu, Dengxuan Mao, Patrick Pan, Ying Liu, Zimei Wu, Yaqi Lyu et al. · 2025 · Chinese Chemical Letters
  40. Suppressing glutamine metabolism in the pancreatic cancer microenvironment can enhance the anti-tumor effect of CD8 T cells and promote the efficacy of immunotherapy
    Jun Fan, Jianfei Chen, Rui Wang, Yisheng Peng, Sunde Tan, Xiaoli Zhang, Hao Tang, Maoshan Chen, Bo Li, Xiaoli Yang · 2025 · Frontiers in Immunology
  41. Structural immunotherapy: Harnessing chemical design to build powerful next-generation therapeutics
    Michelle H. Teplensky, Julianna N. Bourgeois, Sergej Kudruk, Sarah Hurst Petrosko, Chad Alexander Mirkin · 2025 · Proceedings of the National Academy of Sciences
  42. Regulated necrosis at the crossroads of liver inflammation and cancer development
    Mihael Vucur, Vangelis Kondylis, Petr Brož, Tom Luedde · 2025 · Nature Reviews Gastroenterology & Hepatology
  43. Demonstration of SLU7 as a new cancer target
    Carla Rojo, Aaron Otero, María Elizalde, María Azkona, Roberto Barbero, Maria Ujue Latasa, Iker Uriarte, Álvaro Gutiérrez-Uzquiza, Diego Alignani, Laura Guembe et al. · 2025 · Biomedicine & Pharmacotherapy
  44. Low-intensity pulsed ultrasound (LIPUS)-augmented calcicoptosis by calcium-based nanoparticles for enhanced immunogenic cell death induction in triple-negative breast cancer
    Yang Gao, Ziting Xu, Yingshan Gao, Li Zhang, Liang Yu, Qiuyu Li, Minyi Liu, Haibo Lan, Yanyan Zhang, Bingxia Zhao et al. · 2025 · Journal of Nanobiotechnology
  45. Metformin glycyrrhetinic acid binary injectable hydrogel for synergistic tumor immunotherapy via spatiotemporal microenvironment remodeling
    A. Ouyang, Xin Yu Qin, Bo Su, Shaojuan Mo, Jiujun Jiang, Zixin Wang, Yu Li, Jiayu Lu, Yangzheng Lin, Jie Wang et al. · 2025 · Materials Today Bio
  46. Tumor organoid-immune cell co-culture systems for precision oncology
    Lei Cai, Yunfeng Xiao, Feihong Xie, Zongke Yang · 2026 · Frontiers in Cell and Developmental Biology
  47. Landscape of unconventional γδ T cell subsets in cancer
    Parviz Azimnasab-sorkhabi, Maryam Soltani-asl, Mohammad Soleiman Ekhtiyari, José Roberto Kfoury · 2024 · Molecular Biology Reports
  48. A biomimetic solution, albumin–doxorubicin molecular complex, targeting tumor and tumor-draining lymph nodes
    Rui Guo, Lanlan Zhong, Si‐Rui Ma, Bokai Gong, Chen Shen, Zijun Wang, Li Deng, Dong Fu Zhao, Huile Gao, Tao Gong · 2024 · Journal of Materials Chemistry B
  49. Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironment
    Quan Chen, Weijun Wan, Qing Zhao, Juan Li, Yanli Xiong, Yuchuan Yuan, Lu Tang, Xiaofeng Wu, Wei Xing, Wei Guo et al. · 2024 · Frontiers in Immunology
  50. Pharmacological Characterization of GB1908, a Selective Galectin-1 Carbohydrate Binding Domain Inhibitor for the Treatment of Cancer
    Kimberly D. Herman, Ian Holyer, Duncan C. Humphries, James A. Roper, Kristoffer Peterson, Fredrik R. Zetterberg, Anders Pedersen, Alison C. MacKinnon, Robert J. Slack · 2025 · Pharmacology
  51. Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and Toxicity
    Simeng Chen, Yuan Lin, Dan Li, Xiaoru Zhou, Xing Sun, Changyong Yang, Cheng Liao · 2025 · Molecular Cancer Therapeutics
  52. In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma
    Udit Basak, Sumon Mukherjee, Sourio Chakraborty, Gaurisankar Sa, Shubhra Ghosh Dastidar, Tanya Das · 2025 · Scientific Reports
  53. The miR-876-5p/SOCS4/STAT3 pathway induced the expression of PD-L1 and suppressed antitumor immune responses
    Hsuan‐Yu Peng, Yuli Huang, Ping‐Hsiu Wu, Lijie Li, Bou‐Yue Peng, Chia-Yu Wu, Yu‐Lung Lin, Michael Hsiao, Jang-Yang Chang, Peter Mu‐Hsin Chang et al. · 2025 · Cancer Cell International
  54. Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth
    Surajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves, Zeribe C. Nwosu, Ke Xu, Elke van Beek, Priyanka Prakash Desai, Sivasish Sindiri, Sruthi Chempati, Kirsten Remmert et al. · 2025 · Cancer Discovery
  55. Local delivery of IL-15 and anti-PD-L1 nanobody by in vitro-transcribed circILNb elicits superior antitumor immunity in cold tumors
    Dun Niu, Xiaozhuang Ma, Junshi Zhu, Liangbo Sun, Shaotong Zhang, Yaran Wu, Meihua Shan, Xufang Dai, Yaling Liao, Dong Liu et al. · 2025 · Cell Reports Medicine
  56. Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8
    Elias A. T. Koch, Renato Liguori, Alejandro Afonso Castro, Stefan Schliep, Anne Petzold, Anja Wessely, Waltraud Fröhlich, Fulvia Ferrazzi, Julio Vera, Markus Eckstein et al. · 2025 · International Journal of Molecular Sciences
  57. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction
    Yutian Sun, Ming Yang, Qingyuan Zhang · 2022 · Annals of Translational Medicine
  58. Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles
    Carlos Martínez-Torró, Lorena Alba‐Castellón, Luis Miguel Carrasco-Díaz, Naroa Serna, Laura Imedio, Alberto Gallardo, Isolda Casanova, Ugutz Unzueta, Esther Vázquez, Ramón Mangues et al. · 2023 · Biomedicine & Pharmacotherapy
  59. DENDRITIC CELLS IN GLIOBLASTOMA TREATMENT: A MODERN VIEW OF THE PROBLEM AND OWN EXPERIENCE
    Oleksandr Glavatskyi, N. Khranovska, O. Skachkova, Oleksandr I. Gorbach, Hennadii V. Khmelnytskyi, Irina Shuba, Pedachenko Eg, Oksana V. Zemskova, Oksana V. Zemskova · 2023 · Experimental Oncology
  60. The Tumor Microenvironment and Immune Response in Breast Cancer
    Behjatolah Monzavi‐Karbassi, Thomas J. Kelly, Steven R. Post · 2024 · International Journal of Molecular Sciences
  61. Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies
    Gere S. diZerega, Holly A. Maulhardt, Shelagh J. Verco, Alyson M. Marin, Michael Jay Baltezor, Samantha A. Mauro, Marc A. Iacobucci · 2024 · Oncology and Therapy
  62. Individual Survival Distributions Generated by Multi-Task Logistic Regression Yield a New Perspective on Molecular and Clinical Prognostic Factors in Gastric Adenocarcinoma
    Daniel Skubleny, Jennifer L. Spratlin, Sunita Ghosh, Russell Greiner, Dan Schiller, Gina R. Rayat · 2024 · Cancers
  63. Spatiotemporally Controlled T‐Cell Combination Therapy for Solid Tumor
    Meixi Hao, Ying Zhou, Sijia Chen, Yu Jin, Xiuqi Li, Lingjing Xue, Mingxuan Shen, Weishuo Li, Can Zhang · 2024 · Advanced Science
  64. A hot and cold tumor‑related prognostic signature for stage II colorectal cancer
    Ming Zhou, Xiaoxu Ge, Xiaoming Xu, Biao Sheng, Hao Wang, Haoyu Shi, Sikun Liu, Boren Tan, Kailun Xu, Jian Wang · 2024 · Oncology Letters
  65. A computational analysis of the oncogenic and anti-tumor immunity role of P4HA3 in human cancers
    Hongyan Huang, Fu Wei Zhang, Jie Yu, Yan Hong Xiao, Di Zhu, Xiao-Lin Yi, Xiaohua Lin, Ming Li Jin, Hai Yun Jin, Yongsheng Huang et al. · 2024 · PLoS Computational Biology
  66. A Senescence-Associated Gene Signature for Prognostic Prediction and Therapeutic Targeting in Adrenocortical Carcinoma
    Hangya Peng, Qiujing Chen, Lei Ye, Weiqing Wang · 2025 · Biomedicines
  67. The molecular classification of cancer-associated fibroblasts on a pan-cancer single-cell transcriptional profiling
    Bonan Chen, Wai Nok Chan, Fuda Xie, Chun Wai Mui, Alvin H.K. Cheung, Xiaoli liu, Raymond Wai Ming Lung, Chit Chow, Zhenhua Zhang, Shihua Shi et al. · 2023 · Research Square
  68. Transcriptomic analysis reveals potential crosstalk genes and immune relationship between triple-negative breast cancer and depression
    Zhili Zhuo, Wenping Lü, Ling Zhang, Dongni Zhang, Yongjia Cui, Xiaoqing Wu, Heting Mei, Lei Chang, Qingya Song · 2024 · Discover Oncology
  69. Bone Voyage: OPN's Path from Skeleton to Systemic Immunosuppression
    Kyoko Hashimoto, Kazuo Okamoto, Hiroshi Takayanagi · 2025 · Cancer Research
  70. Targeted Inhibition of Tumor Extracellular Vesicle Secretion Improving the Anti‐Tumor Immunity of Lymph Node‐Targeted Vaccines
    Fei Wang, Manqi Yan, Junming Dong, Xinyan Xie, Nan Zhang, Ting Wu, Yu Gu, Yong Hu · 2025 · Advanced Functional Materials
  71. CARG-2020 targets IL-12, IL-17, and PD-L1 pathways to effectively treat melanoma and breast cancer
    Elham Ahmadi, Conner C. Chiari, Bhaskara Reddy Madina, Timur Olegovich Yarovinsky, Marie Marthe Krady, Ju Chen, Bijan Almassian, Valerian Nakaar, Kepeng Wang · 2025 · Scientific Reports
  72. Heterogeneity-optimized method for predicting immune checkpoint blockade response
    Juan Liang, Qihang Guo, Shan Xiang, Yun Wang, Juntao Li · 2025 · Scientific Reports
  73. Single-cell RNA sequencing identifies CD8Teff cell activation as a predictive biomarker in triple-negative breast cancer immunotherapy
    Luhui Mao, Zebang Zhang, Yongjian Chen, Qing Peng, Zhenjun Huang, Wenhao Ouyang, Dongqiang Zeng, Wei Ren, Zifan He, Li Tang et al. · 2025 · Molecular Biomedicine
  74. The activity of immune checkpoint inhibitors in patients with recurrent cervical cancer developed in previously irradiated field: clinical and immunohistochemical investigations
    Seiji Mabuchi, Naoko Komura, Harumi Nakamura, Michihide Maeda, Takeshi Yokoi, Shinsuke Koyama, Tomoko Ueda · 2025 · Journal of Gynecologic Oncology
  75. A clinically relevant pan-cancer prognostic signature derived from T-cell activation immune genes: Experimental validation across malignancies with emphasis on breast cancer
    Jianing Zhang, Xirui Zhou, Yu-tong Wang, Zi-Lu Yi, Linwei Li, Hong Liu · 2025 · Pharmacological Research
  76. Dual-pathway nanoengineering: spatiotemporal control of immunogenic apoptosis and macrophage phenotype reprogramming for augmented antitumor immunity
    Yunfeng Tang, Xiangtian Deng, Min Yi, Dong Wang, Cheng Zheng, Shichang Zhao, Renliang Zhao · 2025 · Journal of Nanobiotechnology
  77. Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy
    Tingting Li, Honglin Huang, Qianyi Zeng, Li Zeng, Ziman Yang, Jinyang Shen, Shun Li, Hong Yang, Ying Liu, Chunhui Wu · 2026 · BMEMat
  78. Cytotoxic lymphocyte heterogeneity in glioblastoma: insights from single-cell and spatial multiomics toward precision immunotherapeutic reprogramming
    Wentao Dong, Yang Li, Zhuolin Wu, Quanlin Fu, Jinshuang Zhao, Bangyue Wang, Jia Yao, Chenglu Lu, Minfeng Tong · 2026 · Frontiers in Immunology
  79. Piezobiomimetic delivery nanosystem converts cold tumors to hot by parallel PANoptosis/STING activation in hepatocellular carcinoma
    E Jiaoting, Yuxuan Zhao, Xiaoling Zhang, Q J Zhang, Ying Xu, Shanshan Liu, He Ding, Jiuxin Zhu, Piaoping Yang, Rui Xie · 2026 · Science Advances
  80. Dendritic cells in cancer immunotherapy: functional barriers, reprogramming strategies and translational challenges
    Ningping Xiao, Chao Chen, Xiuyu Yang, Jiajia Hao, Mian Xie, Jiangtao Wang, Jiayu Xiang, Chang Liu, Xiulin Jiang, Siwei Huang et al. · 2026 · Frontiers in Immunology
  81. Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients
    Yushi Nagaki, Satoru Motoyama, Yusuke Sato, Akiyuki Wakita, Hiromu Fujita, Kohei Kemuriyama, Ryohei Sasamori, Shu Nozaki, Kyoko Nomura, Yoshihiro Minamiya · 2024 · Annals of Surgery Open
  82. Bioinformatic-Experimental Screening Uncovers Multiple Targets for Increase of MHC-I Expression through Activating the Interferon Response in Breast Cancer
    Xin Li, Zi-Lun Ruan, Shuzhen Yang, Qing Yang, Jinpeng Li, Ming‐Ming Hu · 2024 · International Journal of Molecular Sciences
  83. Ultrasound-guided percutaneous radiofrequency ablation combined with anti-PD-1 for the treatment of prostate cancer: an experimental study
    Si Chen, Ruiqing Liu, Shaobo Duan, Beibei Zhang, Yuzhou Wang, Xiaoxiao Li, Yingying Zhao, Zesheng Li, Qi Zhou, Rui Zhang et al. · 2025 · Frontiers in Oncology
  84. A bioactive soluble recombinant mouse LIGHT promotes effective tumor immune cell infiltration delaying tumor growth
    M. Del Río, Oscar-Mariano Nuero-Garcia, Giovanna Roncador, Raquel Garcimartín-Bailon, Juan-Carlos Cubria, Pascal Schneider, J. Rodriguez-Barbosa · 2024 · bioRxiv
  85. Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1
    Borui Tang, Yuting Wang, Liping Li, Cuicui Sun, Jingwen Dong, Ruoqi Li, Jianfeng Wang, Yu Long, Mingxiao Yin, Fei Xie et al. · 2025 · Research
  86. CD80-Mediated T-Cell Suppression by Cancer Stem-like Cells in Head and Neck Squamous Cell Carcinoma
    Mian Xiao, Lin Qiu, Qian Gao, Ruifeng Li, Jing Wang, Yanrui Feng, Xuefen Li, Xi‐Yuan Ge · 2026 · Cells
  87. HSA-nanobinders crafted from bioresponsive prodrugs for combined cancer chemoimmunotherapy–an in vitro exploration
    Matilde Tubertini, Luca Menilli, Celeste Milani, Cecilia Martini, Maria Luisa Navacchia, Marta Nugnes, Manuela Bartolini, Marina Naldi, Daniele Tedesco, Elisa Martella et al. · 2024 · Frontiers in Chemistry
  88. HSA-hijacking nanobinders built on bioresponsive prodrugs for combined cancer chemoimmunotherapy
    Matilde Tubertini, Luca Menilli, Celeste Milani, Cecilia Martini, Maria Luisa Navacchia, Marta Nugnes, Manuela Bartolini, Marina Naldi, Daniele Tedesco, Elisa Martella et al. · 2023 · ChemRxiv
  89. Organ specific microenvironmental MR1 expression in cutaneous melanoma
    Patricia B. Gordon, Woong Young So, Udochi F. Azubuike, Bailey Johnson, James Cicala, Victoria E. Sturgess, Claudia Wong, Kevin S. Bishop, Erica Bresciani, Raman B. Sood et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  90. Treatment-Related Lymphopenia is Possibly a Marker of Good Prognosis in Nasopharyngeal Carcinoma: a Propensity-Score Matching Analysis
    Kegui Weng, Hai-ke Lei, De-Song Shen, Ying Wang, Xiaodong Zhu · 2024 · Cancer Management and Research
  91. Humanized patient-derived xenograft mouse model bearing ovarian clear cell carcinoma
    Zhen Yuan, Huimei Zhou, Dongyan Cao, Jiaxin Yang, Qian Liu · 2024 · Journal of Gynecologic Oncology
  92. Tumor Cells‐Derived FGF ‐2 Promotes Lymphangiogenesis as a Prognostic Marker in OSCC
    Jia Kang, Aoming Cheng, Guanzheng Chen, Lin Zhu, Zhengxue Han, Qiaoshi Xu · 2025 · Journal of Oral Pathology and Medicine
  93. Immune-activating cationic lipo-polypeptides for oncolytic immunotherapy in triple negative breast cancer
    Ziwen Gao, Peng Zhang, Renyong Yin, Junqi Wang, Zhihui Guo, Qi Yao, Guowenlie Gao, Xu‐Feng Huang, Chunsheng Xiao, Yingchao Zhang et al. · 2025 · Science China Materials
  94. NIR-II-activated photothermal therapy using gold nanotetrapods enhances antigen presentation and immune response in colorectal cancer
    Weijia Zheng, Ling Bai, Nawen Du, Ningning Zhang, Shoujun Zhu, Jianting Xu, Fei Chen, Hongxin Tao, Zhaozhi Li, Min Li et al. · 2025 · Nano Research
  95. Senescence-associated miRNAs predict survival and modulate the tumor immune microenvironment via SPOCK1 targeting in clear cell renal cell carcinoma
    Zheng Song, Lei Zhang, Xiyue Song, Wei Luo · 2025 · Urologic Oncology Seminars and Original Investigations
  96. Exploring PKMYT1 as a potential marker for colorectal cancer progression through bioinformatics analyses and experimental validation
    Yuqiang Zhang, Yingwei Chang, Yujie Hu, Zhichao Ding, Zhihui Zhang, Yanbei Wei, Lei Liu, Minghao Yang, Wei Chen · 2025 · Scientific Reports
  97. Next-Generation of Multimode Imaging and Synergistic Therapeutics for Solid Tumors
    Pavithra Kurungottu, A. Sorna Lakshmi, Agnes Sebastian, Aleena Sabu Koshi, Ashwin T. Shaji, S. Karthik, Anushka Balakrishnan, Rajendra Kurapati · 2025 · Springer eBooks
  98. Mechanism by which CAP regulates the “cold–heat” balance in osteosarcoma model mice: an integrative study of metabolomics, transcriptomics, and network pharmacology
    Ziming Wang, Shun Zhang, Shipeng Li, Guosheng Zhao, Yuan Zhang, Xiaohong Zhang, Mingwei Sun, Yun Lu, Enfeng Song, Cantao Quan et al. · 2025 · Journal of Translational Medicine
  99. Protumor Macrophage Polarization Mediated by BMP2/4–ACVR1 Signaling Orchestrates an Immunosuppressive Microenvironment during Tumor Initiation
    Mingchao Wang, Zhihong Song, Hao Yuan, Chang Liu, Wei Wang, Naixue Yang, Keyong Sun, Shanshan Zhang, Xuyang Qin, Jingwei Li et al. · 2025 · Cancer Research
  100. Overcoming tumour resistance in cancer immunotherapy through predictive and pharmacodynamic biomarkers
    Heena Kansal, Vishal Chopra, Kranti Garg, Siddharth Sharma · 2025 · Clinical & Translational Oncology